TickerFactsScreenerDevelopers

Mereo BioPharma Group plc (MREO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2022: -$54.43M2023: -$28.42M2024: -$47.36M2025: -$40.11M-$40.11M
2022Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$40.11M+15.3%
2024-$47.36M-66.7%
2023-$28.42M+47.8%
2022-$54.43M—